Description: |
This trial seeks to determine the effect of androgen deprivation therapy with or without docetaxel on overall survivalĀ in prostate cancer patients with EXTENSIVE metastatic disease (visceral lesions or 4+ bony metastases) and who have been on androgen deprivation therapy for less than 90 days. |
Link: |
|
Site: |
Johns Hopkins Hospital |
Principal investigator: |
Michael Carducci, M.D. |